These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1679571)

  • 41. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents].
    Menninger H; Burkhardt H
    Fortschr Med; 1983 Apr; 101(14):639-45. PubMed ID: 6406333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment].
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Zeminian S; Bambara LM
    Recenti Prog Med; 1998 Jan; 89(1):14-7. PubMed ID: 9549387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
    Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology of auranofin: overview and update.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis.
    Horsfall MW; Shaw JP; Highton J; Cranch PJ
    N Z Med J; 1998 Jun; 111(1067):200-3. PubMed ID: 9673632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Basic and clinical study on combined immunomodulator therapy in rheumatoid arthritis].
    Hoshi K; Mizushima H
    Ryumachi; 1988 Dec; 28(6):457-9. PubMed ID: 2907949
    [No Abstract]   [Full Text] [Related]  

  • 52. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ultrastructural and microanalytic study of gold depots in the synovial membrane of man and animals during treatment with sodium aurothiopropanol sulfonate].
    Laoussadi S; Berry JP; Aubouy G; Delbarre F
    C R Seances Soc Biol Fil; 1981; 175(4):474-84. PubMed ID: 6457670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Herpes zoster--an unusual complication of gold therapy].
    Murav'ev IuV; Tsurko VV; Sigidin IaA
    Ter Arkh; 1987; 59(4):136-7. PubMed ID: 3589991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gold in the treatment of rheumatoid arthritis -- why, when and how?
    Jessop JD
    J Rheumatol Suppl; 1979; 5():12-7. PubMed ID: 114641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral gold in rheumatoid arthritis.
    Drug Ther Bull; 1988 Sep; 26(18):69-72. PubMed ID: 3139386
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effectiveness and complications of chrysotherapy of rheumatoid arthritis].
    Erov NK
    Revmatologiia (Mosk); 1986; (1):11-4. PubMed ID: 2940663
    [No Abstract]   [Full Text] [Related]  

  • 58. [The comparative efficacy of slow-acting (basic) preparations in psoriatic arthritis].
    Burdeĭnyĭ AP; Agababova ER; Korotaeva TV; Kharamil'o LF
    Ter Arkh; 1992; 64(5):54-9. PubMed ID: 1360714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chlorbutin, azathioprine, D-penicillamine and levamisole (decaris) in the treatment of patients with rheumatoid arthritis. IV. Comparative evaluation of their effects on systemic (extra-articular) manifestations of the disease].
    Krel' AA; Kanevskaia MZ; Chichasova NV; Khamishon LZ; Nemchenov EN
    Ter Arkh; 1985; 57(8):44-52. PubMed ID: 3906995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.